Strategic Blueprint’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Strategic Blueprint’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,263	Closed	-$217K	–	567
2022 Q1	$217K	Sell	5,263 -2,128	-29%	-$74.9K	0.03%	462
2021 Q4	$315K	Hold	7,391	–	–	0.04%	370
2021 Q3	$407K	Hold	7,391	–	–	0.06%	272
2021 Q2	$354K	Hold	7,391	–	–	0.06%	281
2021 Q1	$374K	Hold	7,391	–	–	0.08%	207
2020 Q4	$465K	Hold	7,391	–	–	0.12%	153
2020 Q3	$497K	Buy	7,391 +787	+12%	+$43K	0.15%	121
2020 Q2	$277K	Hold	6,604	–	–	0.1%	135
2020 Q1	$208K	Sell	6,604 -7,428	-53%	-$297K	0.12%	118
2019 Q4	$567K	Buy	+14,032	New	+$491K	0.39%	45

Other funds holding SILK

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Strategic Blueprint's SILK Position: Q2 2022 in Review

Strategic Blueprint sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2022, closing a stake of 5,263 shares — an estimated $217K sold.

Strategic Blueprint first reported a position in SILK in Q4 2019 and held it in 10 quarters. The position peaked at $567K in Q4 2019. 139 funds tracked by Wall St. Rank hold SILK as of Q2 2022.

Strategic Blueprint reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Strategic Blueprint sold 5,263 Silk Road Medical, Inc. Common Stock shares in Q2 2022, an estimated $217K.
Strategic Blueprint first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2019 and held it in 10 quarters.
Strategic Blueprint's Silk Road Medical, Inc. Common Stock position peaked at $567K in Q4 2019.
139 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2022.

Based on Strategic Blueprint's 13F filing for Q2 2022, filed 12 Aug 2022.